Daniel Ermann, MD

University of Utah Health

Latest Videos

Non-covalent BTKi efficacy post-covalent BTKi or BCL-2 therapies in cancer treatment, featuring experts Claudia Villa Celi, MD, and Daniel Ermann, MD, for oncology research updates.

Leukemia

12/18/2025

Sequencing BTKi Therapies in Patients With CLL

Claudia Villa Celi, MDDaniel Ermann, MD

1. Two healthcare professionals, a male and female doctor, smiling against a city skyline at dusk, promoting oncology research updates on BTK inhibitors and therapy in CLL.

Leukemia

12/17/2025

SEQUOIA Trial Long-Term Data Support Second-Generation BTK Inhibitors in CLL

Catherine Coombs, MDDaniel Ermann, MD